Cannabinoid Biosynthesis: How Your Plant Builds Potency

What You Need to Know

Here’s what catches most growers off guard: your plant doesn’t produce THC. It produces THCA — tetrahydrocannabinolic acid — which is a completely different molecule that becomes THC only when you heat it. That distinction isn’t semantic. It rewires how you think about genetics, potency ceilings, and why no amount of nutrient tweaking will make a 15% strain test at 25%.

Understanding the biosynthetic pathway — how the plant assembles cannabinoids from raw precursors — is essential for advanced growing. It explains why potency is locked in genetically, why you can’t “feed your way” to higher THC, and why some cultivars have hard limits that no technique can break through. Tahir’s team at the University of Windsor mapped the complete chain from primary metabolites to final cannabinoids, showing the exact genetic and enzymatic bottlenecks that determine what your plant can produce.

The Science

Tahir’s team reviewed the complete biosynthetic pathway of cannabinoids, from primary metabolites all the way through to the final decarboxylated compounds you consume. Here’s the chain:

Step 1 — The building blocks. Two pathways supply the raw materials. The MEP pathway (in plastids) produces geranyl pyrophosphate (GPP), which is a 10-carbon terpenoid building block. The polyketide pathway produces olivetolic acid (OLA) from hexanoyl-CoA — a 12-carbon phenolic compound. These two pathways operate in the trichome cells and draw on primary metabolic carbon.

Step 2 — The universal precursor. An enzyme called aromatic prenyltransferase (APT) fuses GPP with olivetolic acid to produce cannabigerolic acid (CBGA). CBGA is the mother of all cannabinoids. Every single cannabinoid in cannabis — THC, CBD, CBC, and all their variants — starts as CBGA. If you’ve heard of CBG flower, that’s flower from a plant that stops at this stage because it lacks the enzymes to convert CBGA further.

Step 3 — The fork in the road. Three competing enzymes act on CBGA to produce the three major cannabinoid acids: THCA synthase converts CBGA to THCA. CBDA synthase converts CBGA to CBDA. CBCA synthase converts CBGA to CBCA (cannabichromenic acid). These three enzymes compete for the same substrate (CBGA). Your plant’s genetics determine which enzyme it expresses most, and that determines whether your cultivar is THC-dominant, CBD-dominant, or a hybrid.

Step 4 — Decarboxylation. The acidic cannabinoids (THCA, CBDA, CBCA) lose their carboxyl group (-COOH) when exposed to heat, light, or time. THCA becomes THC. CBDA becomes CBD. This is a non-enzymatic chemical reaction — the plant doesn’t do it. You do it when you light a joint, heat an oven, or leave buds in storage for months. Fresh plant material contains almost exclusively the acid forms.

The genetic bottleneck: THCA synthase and CBDA synthase are encoded by genes at a single genetic locus. They share 84% amino acid sequence identity — they’re essentially the same enzyme with a few critical mutations that change their substrate specificity. A plant that is homozygous for the THCA synthase gene (BT/BT) produces predominantly THCA. A plant homozygous for CBDA synthase (BD/BD) produces predominantly CBDA. A heterozygous plant (BT/BD) produces both. This is why crossing a THC cultivar with a CBD cultivar produces offspring with varying THC:CBD ratios — they inherit different combinations of these alleles.

Why you can’t feed your way to higher THC: The maximum THCA concentration your plant can produce is determined by the expression level and catalytic efficiency of its THCA synthase enzyme, which is genetically fixed. Environmental factors (light, nutrients, water) can help the plant reach its genetic ceiling by keeping it healthy and productive, but they can’t raise the ceiling. It’s like a speed limit — you can tune your car to go the speed limit more easily, but the limit itself is painted on the sign. Every module in this curriculum that shows “no NPK effect on cannabinoid concentration” or “no light effect on potency percentage” is telling the same story: the biosynthetic capacity is set by the DNA.

How To Apply This

• Accept that your cultivar’s potency ceiling is genetic. No nutrient, light spectrum, stress technique, or additive will make a 15% THC strain test at 25%. Your job is to help the plant reach its ceiling — not raise it. Every previous module has shown that the controllable variables (light, nutrients, water) affect yield, not potency percentage.

• Understand the THCA → THC conversion when reading lab results. Most lab reports provide “total THC” which is calculated as: Total THC = (THCA × 0.877) + THC. The 0.877 factor accounts for the mass lost during decarboxylation. If a lab reports 22% total THC, the actual THC in the raw bud is close to zero — it’s almost all THCA that will convert when heated.

• If you’re interested in breeding, know that THC:CBD ratio inheritance is relatively simple. It’s controlled primarily by a single locus with codominant alleles. Crossing two high-THC plants produces high-THC offspring. Crossing high-THC with high-CBD produces a 1:1 mix of mixed-ratio offspring. This is one of the more predictable traits in cannabis breeding.

• Work with your genetics’ actual ceiling. If you’re running a properly lit, properly fed, properly watered setup and the potency plateaus, the genetics are the bottleneck. The solution is better genetics, not more expensive nutrients.

Seb’s Corner (Level 2+)

The enzymology of cannabinoid biosynthesis has advanced significantly since Tahir’s 2021 review, but the core pathway remains well-established. THCA synthase (THCAS) is a 545-amino acid, FAD-dependent oxidoreductase that catalyses an enantiospecific oxidative cyclisation of CBGA. The crystal structure (PDB: 3VTE, Shoyama et al. 2012) reveals a buried active site with covalently bound FAD, anchored by His114 and Cys176. CBDAS shares 84% sequence identity with THCAS, and the primary difference in catalytic specificity is attributed to whether the enzyme abstracts a proton from the terminal methyl (CBDAS) or the hydroxyl (THCAS) group of CBGA, directing the cyclisation product. A single amino acid mutation — A414V in THCAS — creates an analogue with threefold higher CBDA production, demonstrating the evolutionary knife-edge between these two pathways. For growers, the practical takeaway is that chemotype (THC-dominant vs CBD-dominant) is one of the most genetically tractable traits in cannabis, controlled by a small number of well-characterised genes. This is why seed banks can reliably label chemotype ratios. Potency within a chemotype (e.g., 18% vs 25% THC in two different THC-dominant cultivars) is likely polygenic, involving variation in THCAS expression levels, trichome density, trichome maturation timing, and GPP supply — all of which are harder to select for and explain why “high potency” seed claims are less reliable than chemotype claims.

Watch Out For

• The nutrient trap: Products claiming to “unlock hidden potency” or “maximise cannabinoid expression” are marketing fiction. No NPK, micronutrient, or additive formula changes the genetics you’re working with. If the ceiling is 20%, that’s the ceiling.

• Decarboxylation confusion: Lab reports showing “22% THC” don’t mean 22% of the fresh bud is THC. Most of that is THCA waiting for heat. Understand the conversion math before comparing results.

• Breeding oversimplification: THC:CBD ratio is simple to inherit, but achieving specific potency targets within a chemotype requires multiple generations of selection for expression levels and supporting traits. High potency isn’t a single-gene trait.

• Fresh vs cured potency myths: Some THCA converts during drying and curing (a few percent), but the major decarboxylation happens when you consume it. Don’t confuse curing effects with the true potency change.

Quiz

1. Your lab report shows “Total THC: 22%”. What percentage of the fresh, uncured bud is actually THC?

• A) Approximately 22%
• B) Approximately 19% (accounting for some drying loss)
• C) Close to zero; almost all of it is THCA
• D) It depends on the terpene profile *

2. THCA synthase and CBDA synthase are:

• A) Completely different enzymes from different gene families
• B) The same enzyme with only small mutations changing substrate specificity *
• C) Enzymes that compete for different substrates (THCA and CBDA respectively)
• D) Enzymes that work together to produce hybrid cannabinoids

3. True or False: Increasing nutrient concentration or light intensity can raise your cultivar’s genetic potency ceiling.

• False * (Explanation: Environmental factors affect whether the plant reaches its ceiling, not the height of the ceiling itself.)

4. A grower crosses a high-THC strain (homozygous BT/BT) with a high-CBD strain (homozygous BD/BD). What THC:CBD ratio will the F1 offspring predominantly produce?

• A) High THC (like the male parent)
• B) High CBD (like the female parent)
• C) A hybrid ratio of both THC and CBD equally *
• D) It’s unpredictable and varies plant-to-plant

5. You’re breeding for increased potency within a THC-dominant chemotype. Why is selecting for “high potency offspring” harder than selecting for “THC-dominant chemotype”?

• Potency within a chemotype is polygenic (many genes involved), while chemotype is controlled by a single locus. You can reliably select for chemotype in one or two generations. Potency requires tracking multiple traits (enzyme expression, trichome density, GPP supply) over many generations.

FAQ

If THCA isn’t psychoactive, why does raw cannabis have any effect? THCA has its own pharmacological activity — anti-inflammatory and anti-emetic properties have been reported — but it doesn’t activate the CB1 receptor that produces the “high.” Raw cannabis juice or raw flower won’t get you intoxicated. You need heat to convert THCA to THC for psychoactive effects.

Why do some CBG strains exist? Did they breed out THCA synthase? Essentially, yes. CBG-dominant cultivars have mutations or absent copies of both THCA synthase and CBDA synthase genes. The plant produces CBGA normally but has no enzyme to convert it further, so CBGA accumulates. When decarboxylated (by heat or time), CBGA becomes CBG. This is a relatively new chemotype that breeders have been selecting for.

Can I make my plant produce more CBGA to convert to either THC or CBD? CBGA supply is rarely the bottleneck. In most cultivars, CBGA is converted to THCA or CBDA as fast as it’s produced. The bottleneck is the synthase enzyme capacity (determined by gene expression) and the supply of precursors from the MEP pathway (determined by photosynthetic carbon flux). Increasing light increases total precursor supply, which is why yield goes up — but the ratio of cannabinoids stays the same because the enzyme ratios don’t change.

Does decarboxylation happen during drying and curing? Slowly, yes. Over weeks of drying and months of curing, some THCA converts to THC spontaneously. THCA and THC can also oxidise to CBN (cannabinol), which is why very old cannabis has a “sleepy” effect — it’s accumulated CBN. Proper storage (cool, dark, airtight) slows both decarboxylation and oxidation, preserving the acidic forms until you’re ready to heat them.

Source

Tahir MN, Shahbazi Raz F, Rondeau-Gagné S and Trant JF (2021). “The Biosynthesis of the Cannabinoids.” J. Cannabis Res. 3:7. doi: 10.1186/s42238-021-00062-4. CC-BY 4.0.